Health Canada
- Status: approved
Sitagliptin combined with Beidougen capsule (Sitagliptin combined with Beidougen capsule) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Beijing Chao Yang Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.